induction agents such as Alfathesin, or for the production of repeatable conditions, desirable for example in research into the relationship between loss of consciousness and changes in the electroencephalogram (Berezowskyj et al. 1976).
A cumulative dose response cltYl'e for loss of consciousness was obtained using 48 lmselected premedicated paticnts presellting for electil'c surgery. Dosage was administered on the basis of lean tissue mass (LTJ!) using a simple 1101ll0gram. The end point for loss of consciousness was the failure of the patient to {!,rasp a light object. Using probit analysis an ED50 for thiopentone ill premedicatcd patients was found to be 2'63mg/k{!, LTM. The sequential up-and-dou:n techllique was then used to determille ED50 values for thiopelltone (2· 70 1IIg/kg LTJ!) , metllOhcxitollc (1·j1llg/k{!, Lnl), propanidid (3·66 mg/kg LTiU) alld Alfathesin (0·014 rill/kg LTM). The experimelltal methods and, ill partiwlar, the administration of doses to patients on the basis of LTJI, «'oldd appear to be responsible for a high In'el oj predictability of respollse ill an apparently hcterogellcolls patiellt population. The ED50 values compared favourably with clinically recommellded doses for induction of anaesthesia, except the ED50 for Alfathesin which 1cas approximately one quarter of that recommended. A n appendix prO'i'idcs some of the mathematical background of the up-and-down sequential technique together with a table of maximu1n likelihood solutions for different sequences and an example of the calculation of an ED50 and its confidence limits

IXTRODUCTIOX
Relatively little information IS available concerning accurate measurement of the potencies of anaesthetic induction agents in human patients. This is due firstly to difficulties in establishing reproducible conditions for administration, distribution and elimination of these drugs in heterogeneous patient populations, and secondly to the absence of steady state conditions following single injections of anaesthetic induction agents.
Clinical training permits an anaesthetist to predict the response of a given patient in most instances. Such an approach is not adequate, however, if one is to evaluate new anaesthetic induction agents such as Alfathesin, or for the production of repeatable conditions, desirable for example in research into the relationship between loss of consciousness and changes in the electroencephalogram (Berezowskyj et al. 1976) .
In the animal laboratory a technique of probit analysis of the cumulative dose response curve for a given drug is frequently used to determine its potency. An estimate of the dose which will be effective in producing a desired end point in 50% of a population, the ED.')O may be obtained. A simplified technique for performing this analysis was developed by Litchfield and \Vilcoxon (1948) and has been employed to study anaesthetic induction agents (Gibson et al. 1959 , Thomas 1967 , Clarke et al. 1968 . The probit analysis technique suffers from the large numbers of patients required to obtain an adequate estimate of the ED50 and from the time required to perform the appropriate calculations. In this paper the up-and-down sequential technique for estimation of the ED50 is compared with the method using probit analysis. The up-anddown sequential technique has been described by Dixon and Mood (1948) and Dixon (1965) and is discussed in the Appendix of this paper. The up-and-down sequential technique is used to calculate relative potencies of the anaesthetic induction agents thiopentone, methohexitone, propanidid and Alfathesin in premedicated patients and to study the effect of premedication on the ED50 for thiopentone.
MATERIALS AND METHODS (i) Selection of Subjects and Drug Administration
Patients aged between 18 and 50 years, undergoing surgery and of American Society of Anesthesiology physical status, I, II or III were accepted for this study. They were classified as "premedicated" if they had received an opiate within 90 minutes of induction of anaesthesia.
The drugs used were sodium thiopentone (Pentothal-Abbot), sodium methohexital (Brietal-Eli Lilly (Australia)), propanidid (Epontol-Bayer) and Alfathesin (CT1341) (a mixture of alphaxalone 9 mg and alphadolone 3 mg per ml in 20% polyoxyethylated castor oil in isotonic sodium chloride-Glaxo). Each drug was administered at the concentration supplied or specified by the manufacturer. Individual doses were made on the basis of the lean tissue mass (L TM) of the patient. Each dose was calculated by applying the difference of height and girth at the umbilicus at expiration to the left side of a nomogram and the total body weight (TBW) to the right side (Figure 1 ).
The use of height and girth at the umbilicus as a method for estimating the lean tissue mass of patients has been shown to be a reliable measure by Wolfsohn (1972) , who utilized the following formulae for his studies: %fat=90-2 (height (ins)--girth (ins)) (i) LTM =TBW-% fat (ii) The nomogram in Figure 1 was constructed from a combination of these formulae, converted to metric units.
(ii) Determination of End Point
Prior to drug administration each patient was made comfortable on the operating room table in a supine position and a 23G scalp vein needle inserted in the back of one hand. The patient was then instructed to hold a 20 ml plastic syringe filled with water between the thumb and index finger of the other hand and to extend the arm approximately 45° above horizontal and to the side of the couch. The calculated dose of the chosen induction agent was then administered by hand at an even rate over a period of 15 seconds. Care was taken to fill the dead space of the scalp vein needle prior to injection.
A positive response was recorded if the patient dropped the syringe within 90 seconds of the commencement of the injection. The anaesthetic induction was allowed to proceed in the usual way once the syringe had been dropped or 90 seconds had elapsed. 
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FIGURE l.-A nomogram derived from the data of Wolfsohn (1972) to calculate lean tissue mass (LTM) in adult patients, using the difference between height and girth at the umbilicus at end expiration and the total body weight (TBW).
RESULTS (i) Pro bit A nalysis Method for ED50 Estimation
Forty-eight premedicated patients were randomly allocated to six dose groups of equal size. The groups were administered 2 ·00,2 '25, 2·50, 2·75, 3·00 and 3·25 mg/kg LTM of thiopentone respectively. Figure 2a shows the percentage of positive responses in each group on a linear scale, plotted against the logarithm of the dose. The curve of best fit has a sigmoid shape with the data points distributed towards the extreme ends of the curve.
Using the method of Litchfield and Wilcoxon (1948) a straight line of best fit can be generated on commercially available probability-log graph paper ( Figure 2b ). The data points conform to this line with a calculated x. 2 value of 0 ·53 which is considerably less than the tabulated value (x. 2 =9·,19, P=()-(l5, n=-1). This finding justifies the assumption that the drawn line is correctly fitted and confirms a normal distribution within the subjects studied. From this line an ED50 of 2·63 mg/kg L nl in premedicated patients can be calculated, with 9fi % confidence limits of 2· 45 < ED50 < 2·83 mg/kg LDI. (
ii) Sequential Up-and-Down Teclmiquefor ED50 Estimation
In this method doses are administered and responses observed sequentially (see Appendix). The sequence is started close to the anticipated ED50 level and the dose interval is set at about one standard deviation of the mean of the expected response for the population. The selection of the dose interval is not difficult and in the sequence shown ( Figure 3 ) only six premedicated patients were needed. The dose interval used for thiopentone was 0·2.') mg/kg LTM, a log dose interval of 0·0-1. The sequence was started by giving the first patient :!. 50 mg/kg LT:\! of thiopentone. As this patient failed to drop the syringe the next patient was given 2·75 mg/kg LTM, and so on for the following sequence-OXOOXX. Using the methods described in the Appendix the ED50 and standard error of the mean were calculated. An estimate of the ED50 of 2· 70 mg/kg LTM with 95% confidence limits of the estimate of 2·37<ED50 <3·08 mg/kg LnI was obtained for thiopentone in a sequence of six premedicated patients. In unpremedicated patients the ED50 value of 2 '95 mg/kg L L\I with 95% confidence limi ts of 2· -15 < ED50 < 3 . 55 mg/kg LT\1 was obtained in another six patients (OXOOXX). The confidence limits of these two values clearly overlap and the distributions were not found to be significantly different using 10d.f.) .
ED50 values in premedicated patients for methohexitone, propanidid and Alfathesin are presented in Table 1 . The sequences obtained and the potencies relative to thiopentone are also shown. 
DISCUSSION (i) Calculation of Dose
The experimental methods used in this study appeared to limit variability within the patient population. Observed patient variables such as age, sex, fat distribution and content and even moderate ill health or dehydration did not make the results unacceptable. The straight line dose response curve, using a probit scale (Figure 2b ) and the various up-down sequences (Table 1 ) demonstrate this.
Other authors have commented on the gross variability in response of patient populations when dosed on the ba:;;is of total body weight. Clarke et al. (1968) attributed part of the variability to variations in arm to brain circulation time. They attributed this to variation Wolfsohn (1972) that dosage based on LTM, reflecting body build, provides a reliable basis for dosage. This study confirms the applicability of this method of dosage to anaesthetic induction agents.
(
ii) Choice of End Point
Loss of the ability to clasp a light object provided a simple and straightforward end point. The observation that responses from groups of patients are normally distributed suggests that the ability of patients to learn and cooperate in this test situation is fairly uniform. The dropping of the object is a clear yes/no answer and is free from observer error. Observation of an end point by an investigator is objective and in this case is not necessarily related to the subjective state of consciousness experienced by the patient. But by using an erid point which incorporates a conscious response of the patient the desired effect of the induction agent is tested by a direct measurement.
Other end points have been used in studies of anaesthetic induction agents. Loss of eyelash reflex has been used by Coleman and Green (1960) and Green and Jolly (1960) , however this end point involves constant interference with the patient and also risk to the patient of corneal injury. The test is in fact a stimulus to the patient and could well distort the results. As well, a reflex response is not necessarily a measure of consciousness in contrast to a test involving cooperation by the subject. The doses of an agent required for a minor surgical procedure has also been used as a measure of potency (Coleman and Green 1960, Green and Jolly 1960) . Such an end point involves the extension of the use of the drugs from true induction agents to the maintenance of anaesthesia. This may lead to confusion of the hypnotic action of a drug with its ability to suppress reflex activity.
The assessment of "unconsciousness" by an observer (Thomas 1967 , Clarke et al. 1968 can incorporate a blind technique but again measures depression of reflex or involuntary activity which may again be unrelated to the state of consciousness.
(iii) Statistical Technique
The most accurate estimates of the ED50 for anaesthetic induction agents have been derived from the cumulative dose effect curves for the drug, utilizing the probit analysis technique. The usefulness of the technique is limited, however, by the large numbers of patients required and by the tedious calculations involved in obtaining the ED50 estimate and confidence limits. On the other hand the sequential technique employs few subjects and only simple calculations are needed (see Appendix). Also, the presentation of patients in a sequential manner and the short time between dosage and the onset of a measurable effect favour such a technique for investigations in anaesthetic practice. The results for thiopen-tone in premedicated patients using the sequential technique compare very favourably with those obtained using the probit analysis.
(iv) Potency of Anaesthetic Induction Agents
The ED50 values for thiopentone, methohexitone and propanidid in premedicated patients compare favourably with doses of these agents employed in clinical use (see Table  1 ). These values represent 68%, 69% and 73% respectively of the clinical dose. The ED50 is, of course, the point where 50% of patients lose the ability to cooperate in the test. The somewhat higher clinical dose being reasonable to ensure that the remainder of patients in the normally distributed population are rendered unconscious but not so large as to cause unwanted side-effects of the drugs. Clarke et al. (1971) determined that the acceptable anaesthetic induction dose for Alfathesin falls in the range 40-100 !Ll/kg. This dose range was derived from an objective assessment of a large number of patients on the basis of "acceptable inductions". The major criteria for acceptability being freedom from ex citatory effects, hiccup and marked respiratory depression. The ED50 for Alfathesin was found in this study to be approximately one quarter of the recommended clinical dose. It is apparent from this result that dosage well in excess of that required for the hypnotic effect of the drug is recommended to minimise unwanted excitatory side effects in some patients. This flexibility in the choice of an acceptable dose would appear to be a great advantage of Alfathesin. This is in contrast to methohexitone where ex citatory side effects are not uncommon but where dosage is restricted by respiratory and cardiovascular side effects (Barron and Dundee 1967) and to propanidid where dosage would appear to be restricted by its hypotensive effect (Wyant and Zoerb 1965) . The potencies, relative to thiopentone, of methohexitone (2' 44) and of propanidid (0· 74) are in close agreement with those of Clarke et al. (1968) who obtained values of 3·3 and 1·1 respectively, testing at the 90% level of loss of the ability of patients to count.
From these results we can conclude that the up-and-down sequential technique for estimation of the ED50 of anaesthetic induction agents is extremely efficient as a statistical method, ideally suited to investigations involving anaesthetic patients. The use of the lean tissue mass, estimated from the total body weight, height and girth of patients would appear to have removed much of the variability in a heterogeneous population. The end point of failure to hold a light object proved to be a simple, reproduce able and easily learned indicator of onset of action of the anaesthetic induction agents. The failure of conscious cooperation of the patient would seem to relate well to the onset of unconsciousness in the clinical situation. in this project.
ApPENDIX
The Up-and-Down Sequential Method/or Small Samples The relationship between drug dose and the effect on an individual, the nature of individual variation, the significance of frequency distribution and the meaning of ED50 have been discussed by Fingl and Woodbury (1975) .
The usual method for determining an ED50 is to divide a sample population into approximately equal groups and to allocate each group to a particular dose level. The percentage response at each dose level is then measured. For suitabl y selectcd dose levels the percentage response will be close to zero for the lowest dose and close to one hundred percent for the highest dose.
If the percentage response for each group is plotted against the logarithm of the dose, a cumulative response curve can be fitted. Graphically, it appears as a sigmoid shaped curve. Mathematically, for a homogeneous population with the log-dose representing a normally distributed variate, the cumulative response curve becomes a cumulative normal distribution. Then, for an underlying normal curve of mean [1. and standard deviation cr, the probability P of a response to a dose x is given by :
where 1=(x-[1.)/cr (Brownlee, Hodges and Rosenblatt 1953) .
The value of f1. and cr of the underlying normal distribution determine the ED50 and its confidence limits since this represents the distribution of individual effective doses of the popUlation.
Bliss (1935) and other authors, have linearised the quantal dose effect curve by the use of pro bits or the plotting of raw data on probability-logarithmic graph paper to produce a pro bit line. Using this line either a 50% response level (ED50) or 95% response level (ED95) or any other level can be read off.
Unfortunately these methods involve fitting of a line by graphical or iterative means and tedious calculations to determine confidence limits. The method of Litchfield and \Vilcoxon (1948) attempts to simplify this procedure.
The technique which concentrates doses around the 50% response level, theup-and-down sequential method, was originally developed for explosives research in Dixon and Mood (1948) introduced the technique to pharmacological research. Brownlee, Hodges and Rosenblatt (1953) pointed out the efficiency of the method when applied to small samples. And then Dixon in 1965 described an improved up-and-down sequential technique which employed maximum likelihood estimates for short sequences to provide estimates of high statistical efficiency with uniform variance.
Application 0/ the Up-and-Down Method
As described in this paper, some initial testing of the sample population is required to determine the dose range that contains the ED50. Doses are converted to logarithms and a series of log-dose levels are chosen with interval d being approximately equal to the standard deviation for the population cr. The value of d can lie in the range ±50% of cr without deterioration of results, and can therefore be estimated knowing that 68% of subjects fall in the range ±cr of the mean of a normally distributed population.
Subjects are administered doses sequentially. The first dose Xo is chosen by the experimenter, and should be as close as possible to the anticipated ED50. Subsequent subjects are then given doses, increased by d following a non-response of the previous subject and decreased by d following a response.
To ensure reasonably accurate ED50 estimates, with uniform variance, a fixed nominal sample size N should be selected for each series of ED50 determinations, although the actual number of patients tested will be determined sequentially. A series with N equals 6 provides sufficiently good estimates with little to gain by further increasing the sample size.
The actual number is only increased if like responses occur at the start of a sequence. Then the series must be increased above the nominal sample size by the number of like responses, less one (see Table 2 ).
Calculation oj Mean and Confidence Limits
Once a six response sequence has been established so that the first two responses are not the same, an estimate of the ED50 can be computed.
For a sequence OXOXXO, the probability of this outcome is given by the product of the probabilities of each outcome.
Incorporating equation (iii), abbreviated F(x),
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Assuming that cr=d, this represents a function in terms of Xo and fL. The value fL being the mean of the population, the ED50 to be determined, and Xo the first dose of the sequence.
The maximum likelihood method may be used to analyse the above function in order to determine the probability associated with that sequence when different values of Xo -fL are substituted. A likelihood function can be expressed in terms of Xo and fL and, by either numerical methods or by differentiation, values of xo-fL can be determined which" maximize" P for the sequence. The most likely value of fL for the sequence can then be expressed in terms of Xj' the final dose of the sequence, so that fL=E(log ED50) =xj+kd (v) where E(log ED50) is the expected log ED50.
Values of k can be determined for all possible sequences of outcomes. Table 2 , using the data of Dixon (1965) . gives values of k for all possible sequences where N=6.
The maximum likelihood method of estimation is particularly suitahle for determining the mean square error (~iSE), \\'here
for sequences S, (xo±id, i=O, 1, 2, . . 5). Again, maximizing P for the sequence in terms of Xo -[1., pro\'ides maximum likelihood estimates of the .\ISE which turn out to be almost independent of Xo and [1. and remarkably stable even with a \\"ide \'ariation in the "al ue of a.
An estimate of a and if desired the slope of the common probit line for the subject population may be estimated in the knowledge that the root ;\lSE may be equated to the standard error of the ED50 value. For a sequence with X = 6 the standard error of the ED50 is O· 56a assuming" that a is homogeneous among experiments, and that the analysis of variance design is adequate to cstirnate any interactions which may exist among experiments" (Dixon, l!l65) .
In summary the use of the maximulll likelihood method for ol;taining estimates of the EDi,O from the up-and-down sequential technique provides:
(i) optimal estimates of the ED50 for a given sequence (ii) an extremely uniform error variability which, despite the initial guesswork required for the technique, provides predictable confidence limits for the results. Example For the determination of the ED50 for thiopentone in premedicated patients, a starting dose of 2·50 mg/kg LT'\I was chosen and a dose interval of approximately 0·2;"; mg(kg LT'\I. The logarithm of this dose being 0·3DS and the log increment 0·040. The sequence obtained was OXOOXX (Figure 3) . Then from the log-final dose (0,438), the value of k for this sequence from Table 2 (-O·I6!l) and the log-dose interval \0'040) E(log ED.;O) =0·438 -0 ·169 X 0·040 =O·4:H ... E(ED50)=2·70.
To obtain \Jii% confidence limits it is necessary to perform the calculation in terms of the transfor-med (logarithmic) variate.
From Table 3 
